(NP (NP (NP (NN Glucocorticoid) (NN receptor)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN lupus) (NN nephritis))))) (: :)) (NP (NP (NN relationship)) (PP (IN between) (NP-COOD (NP (NP (NN receptor) (NNS levels)) (PP (IN in) (NP (JJ mononuclear) (NNS leukocytes)))) (CC and) (NP (NP (NN effect)) (PP (IN of) (NP (NN glucocorticoid) (NN therapy)))))) (. .)))
(S (NP-SBJ (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (JJ clinical) (NN significance)) (PP (IN of) (NP (NP (NN glucocorticoid) (NN receptor) (NN determination)) (PP (IN in) (NP (NP (CD 20) (NNS patients)) (PP (IN with) (NP (NP (JJ systemic) (NN lupus) (NN erythematosus)) (PRN (-LRB- -LRB-) (NP (NN SLE)) (-RRB- -RRB-)))) (SBAR (WHNP-28 (WP who)) (S (NP-SBJ (-NONE- *T*-28)) (ADVP-TMP (RB afterwards)) (VP (VBD developed) (NP (JJ nephrotic) (NN syndrome))))))))))) (. .))
(S (NP-SBJ (NP (NN Glucocorticoid) (NN receptor) (NNS concentrations)) (PP (IN in) (NP (NP (JJ mononuclear) (NNS leukocytes)) (PRN (-LRB- -LRB-) (NP (NNS MNL)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT these) (NNS patients)))) (VP (VBD were) (ADJP-PRD (JJ comparable) (PP (IN with) (NP (NP (DT those)) (PP (IN in) (NP-COOD (CC both) (NP (NP (JJ other) (NNS patients)) (PP (IN with) (NP (NN SLE)))) (CC and) (NP (JJ healthy) (NNS persons)))))))) (. .))
(S (NP-SBJ (NP (NN Improvement)) (PP-COOD (PP (IN in) (NP (JJ urinary) (NN protein) (NN excretion))) (CC and) (PP (IN in) (NP (NN disease) (NN activity)))) (, ,) (SBAR (WHNP-29 (WDT which)) (S (NP-SBJ-30 (-NONE- *T*-29)) (VP (VBD was) (VP (VBN scored) (NP (-NONE- *-30)) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NNP SLE) (NNP Disease) (NNP Activity) (NNP Index) (NN system)) (PP (IN of) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Toronto)))))))))))) (, ,)) (ADVP (RB closely)) (VP (JJ related) (PP (TO to) (NP (NP (DT the) (NN glucocorticoid) (NN receptor) (NNS concentrations)) (PP (IN in) (NP (NP (NN MNL)) (VP (VBN isolated) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (JJ corresponding) (NNS patients))))))))) (. .))
(S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (NP (NN glucocorticoid) (NN receptor) (NN determination)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN lupus) (NN nephritis)))))) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT a) (JJ predictive) (NN clue)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG assessing) (NP (NP (NN responsiveness)) (PP (TO to) (NP (NN glucocorticoid) (NN therapy)))))))))) (. .))
